NuCana plc (NCNA) stock

NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 19, 2026Score 1/30

$0.93−0.01 (-1.06%)

Close on Nov 12, 2026Market cap $3.87MP/E –Yield –

NuCana gross margin

Gross margin is gross profit as a percentage of revenue.

NuCana has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?